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Ethyl Maltol (EM) is a flavoring compound commonly used in the food 
industry and has been reported to bind and mediate the transport of iron into cells 
(CDC, 2017). Since EM is highly lipophilic, it is hypothesized to easily pass through cellular plasmid 
membranes and blood brain barrier (BBB). Unwanted iron entry into the brain could be cytotoxic owing 
to the generation of reactive oxygen species. To protect against iron mediated cytotoxicity, several genes 
including amyloid precursor protein (APP) are involved in iron export. Several investigations have 
suggested a relationship between iron build-up and Alzheimer’s disease (AD) (Shea et al., 2016). Risk 
attributable to genetics accounts for approximately 5% of AD cases (Shea et al., 2016). Accordingly, it is 
important to understand factors that increase the risk of AD such as lifestyle and environmental exposures. 
Our hypothesis is that APP is protective against xenobiotics that disrupt iron homeostasis. Human 
neuroblastoma SH-SY5Y cell line was used because it expresses functions expressed by human neurons. 
We established the SH-SY5Y cell line overexpressing APP. The following assays were employed: MTT 
assay for cell viability; Calcein AM for labile iron; qRT-PCR and western blots for gene expression. 
Cytotoxicity was observed in EM-treated cells for 72 hours at 0.3mM. Increases in p21 and 14-3-
3σ expression indicated the activation of a p53 response. The mechanism appears to involve disruption of 
iron homeostasis. Increases were detected in the expression of the iron transporter genes DMT1 and TfR1. 
Increases were also observed in labile iron which were confirmed in HEK293 using a reporter gene 
construct. Moreover, EM-mediated induction of DMT1 and TfR1 was attenuated in SH-SY5Y-APP cells.  
Our studies have the potential to help understand APP’s function in neurons and its mechanisms in 
protecting against toxicity caused by iron dysfunction. Altered processing of APP might disrupt iron 
homeostasis resulting in neuronal death. Overall, our work provides novel insights regarding the etiology 
of AD and identifying factors that increase AD risks. 
Primary Reader and Advisor: Dr. Joseph Bressler 
Secondary Reader: Dr. Jonathan Coulter
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1. Introduction
Neurodegenerative diseases refer to disorders caused by the progressive death or loss of function
of neurons (Fahn et al., 2011). Common neurodegenerative diseases include Parkinson’s, Alzheimer’s and 
Huntington’s diseases. Alzheimer’s disease (AD) currently affects 5 million people in the United States, 
with an approximate death rate of 55%, and this number is continuously increasing (CDC, 2017). The 
population over 65 years old is twice as likely to be diagnosed with AD, though symptoms and pathology 
likely begin years before diagnosis (Liu et al., 2018).  
AD is characterized by memory loss at early stages, and dyslexia, directionality loss, and anxiety 
at later stages (Cheng et al., 2013). As the condition worsens, patients’ mental activities, including 
cognitive behaviors and emotional reactions, and their regular body functions are affected (Ikonomovic et 
al., 2011). Approximately 5% of AD cases are familial suggesting vast majority of cases involve 
environmental factors (Shea et al., 2016). Accordingly, it is important to learn about the environmental 
exposures and AD as well as other neurodegenerative diseases (Shea et al., 2016). The lack of cure for 
AD as well as the expansive and extensive care required for patients make it urgent to study this public 
health problem. 
The pathogenesis of AD is primarily driven by extracellular deposition of β-amyloid and 
intracellular accumulation of tau protein (Agamanolis, 2016). β-amyloid (Aβ) is formed by the cleavage 
of a type I transmembrane protein — Amyloid Precursor Protein (APP) (Liu et al., 2018). During the 
amyloid degradation pathway of APP, peptides Aβ40 and Aβ42 are formed and can cause neurotoxicity 
and ultimately AD (Liu et al., 2018). 
Disruption in iron homeostasis is also a possible factor involved in the development of AD. As an 
essential metal, iron is required in multiple cellular functions and participates in DNA, RNA and protein 
synthesis (Liu et al., 2018). Since the brain is an energy-demanding organ which requires iron for 
mitochondria to synthesis ATP, brain iron homeostasis is especially important. When iron homeostasis is 
disrupted, brain iron accumulation induces the formation of ferritin-associated plaques and can cause 





species (ROS), causing lipid peroxidation and DNA damage. Multiple studies have found excess iron in 
AD patients’ brains by both magnetic resonance imaging (MRI) data and biochemical measurements (Liu 
et al., 2018).  
The homeostasis of iron in cells is tightly regulated by four major proteins. Transferrin receptor 1 
(TfR1) and divalent metal transporter-1 (DMT1) regulate iron uptake, while ferroportin (FPN) regulates 
iron export and ferritin (Ft) regulates iron storage (Liu et al., 2018). The mRNAs of iron transporters have 
iron response elements (IRE) at the 3’ untranslated regions and the mRNAs of FPN and ferritin have IREs 
at the 5’ end. When cells are iron-deficient, iron-related proteins (IRPs) bind to the IRE resulting DMT1 
and TfR mRNA stability and inhibition of FPN and ferritin translation. Consequently, more iron is 
brought into the cell. When iron levels are sufficient, ferritin and FPN protein are synthesized thereby 
decreasing levels of iron availability (Zhou et al., 2017).  
In the intestine, non-heme iron is transported in the ferrous Fe2+ form through DMT1 (Liu et al., 
2018). The absorbed iron can be stored in ferritin or exported out of the intestinal cell through FPN. In 
addition to the IRE, another layer of iron homeostasis is regulated at FPN. The polypeptide hepcidin 
binds to FPN and prevents the release of iron from cells (Silva et al., 2015). The unutilized Fe2+ will be 
oxidized to Fe3+ with the assistance of ferrous oxidase or ceruloplasmin and transported out of the cell 
through FPN1 located on the cell surface (Silva et al., 2015).  
APP also has a role in regulating iron homeostasis in the brain. APP mRNA contains an IRE 
element in the 5’UTR that can bind to IRPs (Silva et al., 2015). An increase in the levels of APP protein 
was reported during iron influx due to increased translation of APP mRNA. (Cho et al., 2010). APP has 
been proposed to participate in iron homeostasis by stabilizing the iron exporter FPN. If cells lacked APP, 
it would be expected that higher levels of ferritin, and lower levels of TFR1 would be observed because 
less iron undergoes transport. Indeed, a previous study found higher levels of intracellular iron and ferritin, 
and lower levels of TfR1 in APP knockout mice (Wong et al., 2014). Additionally, it would be expected 
that the absence of APP would increase oxidative stress., considering that ferrous form mediates the 





Brain iron dysregulation can contribute to the development of AD not only through the generation 
of ROS but also the promotion of β-amyloid formation. In multiple studies, brain iron accumulation 
induced the aggregation and deposition of β-amyloid and neurofibrillary tangles formation through the 
interaction of iron with APP’s IRE site (Silva et al., 2015). Iron has the ability to induce APP cleavage on 
the Aβ domain, causing the increased production of β-amyloid. The excess Fe3+ bound to β-amyloid is 
converted to Fe2+ through the redox activity and induce ROS, causing the cleavage of Aβ42 into 
neurotoxic β-amyloid oligomers and development of AD (Lane et al., 2018).  
Considering the involvement of iron homeostasis in AD, increased risk of AD might be due to 
exposure to xenobiotics that disrupt iron homeostasis. One such xenobiotic that has gained popularity is 
ethyl maltol (EM, C7H8O3) because it is a common constituent in e-cigarettes. It is also widely used as an 
aromatic additive in food, beverages, pharmaceutical products, and health care products. The FDA 
classifies EM as “generally recognized as safe (GRAS)” if used at recommended levels, although the 
guidelines were based on very limited research (FDA, 2014). Recent studies show EM’s possible role in 
facilitating uptake of metals and its ability to form a toxic EM-Fe complex (Li et al., 2017). Unwanted 
iron entry could be cytotoxic owing to the generation of reactive oxygen species (ROS).  
Considering EM is highly lipophilic and volatile, EM could easily pass through the blood brain 
barrier and enter the brain, which raises the possibility that exposure to EM, and other xenobiotics that 
display interactions with iron, are risk factors for AD and other neurodegenerative diseases (Schoenborn 
et al., 2014, Li et al., 2017). The goal of my research is to determine whether EM mediates neuronal 
degeneration by disrupting iron homeostasis. My research is also examining the involvement of 
Alzheimer’s Disease hallmark gene – Amyloid Precursor Protein (APP) in regulating iron. A disruption in 
APP processing could compromise the ability of the neuron to regulate iron homeostasis. The 
combination of the loss of APP, and exposure to chemicals such as EM that disrupt iron homeostasis, 
could lead to neuronal death and neurodegeneration. 
 





2.1 Cell culture 
The human neuroblastoma SH-SY5Y cell line was used to test our hypothesis. Cells were grown 
in Dulbecco Modified Eagle Medium (DMEM) high glucose with 10% fetal bovine serum (FBS). Cells 
were fed with fresh medium 3 times a week and passaged in 1:4 ratio with 0.25% trypsin when they reach 
about 80% confluency.    
SH-SY5Y cells differentiate and form neurite and other phenotypes associated with neurons 
(Kovalevich et al., 2013). SH-SY5Y cells were differentiated with 10 μM trans retinoic acid (RA) in 
media containing 2% FBS and antibiotics (Penn strep) at 1:100 dilution. Neurite outgrowth and the 
expression of neuronal markers were observed at 3 days after differentiation.  
 
2.2 Establishing SH-SY5Y expressing amyloid precursor protein (APP)  
SH-SY5Y cells were plated in 6-well plates at a density of 400,000 cells per well and transfected 
the following day with pEGFP-n1-APP (69924, Addgene) plasmid using the jetOPTIMUS transfection 
reagent from Polyplus-transfection. Transfected cells overexpressing APP were selected by adding 50 μM 
of neomycin (G418) for 7 days. Resistant cells were grown and cryopreserved. 
 
 
Figure 1. Establishing an APP overexpressing SH-SY5Y cell line.  (A) Naïve SH-SY5Y cells (B) SH-
SY5Y cells expressing high levels of APP (eGFP). (C) Relative expression of APP mRNA level 
comparing Naïve SH-SY5Y cells and selected SH-SY5Y APP cells. Relative gene expression was 
quantified by normalizing to housekeeping gene RPLPO by Bio-Rad CFX manager software. Results are 
































expressed as the mean ± S.E.M. Unpaired T-test was performed to test the significance between two 
groups. F test was performed to compare variances. ***,  p<0.01(One-sample t-test). 
 
2.3 Transient transfections 
HEK 293 cells were grown in DMEM with 10%FBS. Cells were plated in 6-well plates at a 
density of 400,000 cells per well and transfected with the IRE-containing plasmid pIRE-YIC (Clontech) 
the following day with jetOPTIMUS transfection reagent. Cells were transferred into 96-well plates and 
treated with ethyl maltol and deferoxamine 2 days after transfection. 
 
2.4 The 4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability assay 
The MTT assay is an indirect measurement of cellular respiration (Chacon et al., 1997). MTT is 
converted to MTT-formazan via mitochondrial dehydrogenase enzymes, resulting in a colorimetric 
change (Chacon et al., 1997). To conduct the assay, cells were plated in 96-well plates at a density of 
40,000 cells per well and treated with EM at different concentrations at 24 hours after plating. MTT was 
made at a 12mM stock solution and added to the cells to achieve a 1.2mM final concentration. The cells 
were returned to the incubator, and at 2 hours after adding the MTT, media was aspirated from the wells 
and 200 μL of dimethyl sulfoxide was added to each well to solubilize the MTT crystals. MTT-formazan 
absorbance was read at 540 nm wavelength on Molecular Devices SpectraMax M5 SoftMax Pro 7.0.3. 
Background absorbance was measured by adding 10% SDS to wells of untreated cells prior to adding 
MTT.  Percent viability was computed by the following formula, where 𝑋"!"#!$%&!'()*  refers to the 
average absorbance measurement of 6 biological replicates, 𝑋"+,+  refers to the average absorbance 










2.5 RNA isolation and Real-Time PCR   
Total RNA was extracted from adherent SH-SY5Y cells with TRIzol Reagent. The phases were 
separated with chloroform and the RNA was precipitated with 100% isopropanol. The precipitate 
containing the total RNA was washed with 75% ethanol to remove impurities. RNA was resuspended in 
nuclease-free water and the concentration of RNA was quantified with NanoDrop. First-strand cDNA was 
synthesized using Oligo(dT)12-18 (500 μg/mL), 10mM dNTP Mix, 5X first-strand Buffer, M-MLV RT 
reagent purchased from Invitrogen. 
Levels of mRNA were quantified and analyzed using Bio-Rad CFX Manager software to 
compute the relative quantity (ΔCq) and normalized with housekeeping gene RPLPO to compute the 
normalized expression (ΔΔCq).  
The primers sequences for amplification of the target genes can be found in table 1. 
Table 1. Revers and forward primers used for RT-PCR. 
Gene names Forward 5’ - 3’ Reverse 3’ - 5’   
RPLPO GCAGCATCTACACTGAAG CACTGGCAACATTGCGGAC 
DMT1 GCCTTTATGGGTCCCGGATT  CAGCTTGTGACCCTGATTGC 
APP GGCCCTGGAGAACTACATCA AATCACACGGAGGTGTGTCA 
p21 TGGACCTGGAGACTCTCAGG TCCAGGACTGCAGGCTTCCT 
14-3-σ GGCCATGGACATCAGCAAGAA CGAAAGTGGTCTTGGCCAGAG 
TfR1 ATACGTTCCCCGTTGTTGAGG GGCGGAAACTGAGTATGGTTGA 
 
2.6 Western blots 
SH-SY5Y cells and SH-SY5Y APP cells were plated at 2,000,000 cells per 10 cm2 plate and 
treated at 24 hours after plating. To harvest protein, cells were collected by scraping into PBS, pelleted, 
and protein was extracted with RIPA lysis buffer containing protease inhibitor and phosphatase inhibitor. 





lysates at 15,000g for 10 minutes and then harvesting the supernatant. Protein concentration was 
measured using the Bradford assay with Molecular Devices SpectraMax M5 SoftMax Pro 7.0.3.  
SDS-PAGE was performed on 4-20% gels subjected to 200 and 400 mA for 40 minutes Protein 
was transferred to a nitrocellulose membrane at 200V, 400 mA for 1 hour. The nitrocellulose membrane 
was incubated with 1X PBS+ 1% Casein Blocker (Bio-Rad) for 1 hour to prevent non-specific binding. 
The nitrocellulose membrane was incubated with primary antibodies Transferrin receptor 1 (CD71, 
D7G9X XP Rabbit mAb from Cell Signaling) at 1:1000 and p21 (Waf1/Cip1 (12D1) Rabbit mAb from 
Cell Signaling) at 1:1000 overnight at 4 °C. After washing, the secondary antibody IRDye® 800CW Goat 
anti-Rabbit IgG (Li-cor) was added for an hour at room temperature. After washing, images were taken 
with Li-cor Odyssey. Band density was analyzed with Image Studio. Levels of p21 and TfR1 are 
expressed by normalizing to β-actin (Sigma-Aldrich, A1978). 
 
2.7 Intracellular iron measurement   
The cellular labile iron pool (LIP) consists of iron not bound to protein and can trigger the 
generation of reactive oxygen species (ROS). The fluorescent dye Calcein AM is used to measure the LIP 
because it binds to labile iron resulting in quenching. SH-SY5Y cells were plated in 24-well plates at a 
concentration of 50,000 cells per well, and treated with Ethyl Maltol or deferoxamine at one day after 
plating. After a 24-hour treatment, medium was aspirated and Calcein AM (RnD Systems, 4892-010-K) 
was added to cells at a final concentration of 4μM. Cells were trypsinized after a 15-minute incubation 
with calcein and transferred into 96-well Costar Black Walled plate at 30,000 cells per well. Level of 
fluorescence was read at 490 nm excitation and 520 nm emission wavelength on Molecular Devices 






2.8 Immunostaining for γ-H2AX 
γ-H2AX foci indicate sites where DNA double strand breaks are being repaired. SH-SY5Y cells 
were plated on poly-L-lysine (PDL)-coated cover slips at 50,000 cells per well in 24-well plates. SH-
SY5Y cells were treated with Ethyl Maltol for 36 hours.  Positive control was accessed with treatment 
with 3 μM etoposide for 2 hours. SH-SY5Y cells were fixed with 4% PFA for 20 minutes and 
permeabilized with 0.2% Triton-X-100 for 10 minutes. Cells were incubated with 1% PBS-BSA to 
prevent nonspecific binding of antibodies. Antibody against γ-H2AX (Ser139) primary antibody (mouse 
monoclonal, clone JBW301, EMD Millipore; #05-636) (2 μg/mL) was added overnight at 4 °C. After 
cells were washed with PBS, fluorescent labeled Goat anti-Mouse IgG Secondary Antibody was added 
for 1 hour at room temperature. After washing with PBS, coverslips were mounted onto slides with 4′,6-
diamidino-2-phenylindole (DAPI) to stain nuclei and anti-fade reagent. Percentage of cells display foci 
was computing by dividing the number of cells with 5 foci or more by the total number of cells and 
multiplying by 100.   
 
2. Results   
3.1 EM is cytotoxic to SH-SY5Y cells and the overexpression of APP protects against EM-mediated 
toxicity 
Cell viability should be compromised after exposing cells to chemicals that disrupt iron 
homeostasis. Indeed, approximately a 50% decrease in viability was observed in SH-SY5Y after a 72-
hour treatment with 1 mM EM (Fig. 2). In contrast, an approximately 25% decrease in viability was 






Figure 2: EM dose response curve comparing naïve SY-SH5Y cells and SH-SY5Y cells over 
expressing APP. A dose response curve was generated with Prism 8 in the method of one-way ANOVA 
and a Tukeys’s HSD was performed to validate the normality of the data. Each value is derived from 6 
replicates ± S.E.M. ****, p< 0.0001.  
 
3.2 EM increases expression of the p53 regulated genes p21 and 14-3- σ and induced p21 was found 
in SH5Y-APP cells  
The p53 pathway is activated when cells undergo stress responses such as hypoxia and DNA 
damage resulting in the inhibition of the cell cycle. Levels of the cell cycle checkpoint genes 14-3-3σ and 
p21 mRNA increased by 2-fold and 3-fold, respectively, when treated with 0.3mM EM for 72 hours 
(Fig.3A). About 4-fold induction of p21 relative protein levels was found in SH-SY5Y APP cells while 





















































Figure 3: EM induces the expression of  14-3-3σ and p21. (A) Relative gene expression was quantified 
by measuring levels of mRNA and normalizing to RPLPO by Bio-Rad CFX manager software. (B) 
Western blot analysis of  p21 and β-actin. (C) Relative protein levels were analysed with Image Studio 
and normalized to β-actin.  **, p<0.05. ****,  p<0.0001 (ANOVA, Tukey posthoc test) 
 
3.3 EM induces the expression of divalent metal transporter 1 (DMT1) and transferrin receptor 
(TfR1) which are both attenuated in SH5Y-APP cells   
Given that EM binds iron and is also highly membrane permeable, the possiblity was investigated 
that EM decreases viabilty by disrupting intracelluar iron homeostasis. Greater than a 20-fold induction in 
DMT1 mRNA was observed in SH-SY5Y cells treated with 0.3mM EM for 72 hours compared to the 
control group (Fig.4A). In constrast, the induction of DMT1 was 5-fold in the APP expressing SH-SY5Y 
cells. EM also induced TfR1 mRNA expression in SH-SY5Y cells treated with 0.3mM EM for 72 hours 
(Fig.4B). A1.5- fold increase was observed in TfR after treatment with EM for 72 hours at 0.3mM 
(Fig.4C, D). Interestingly, the TfR1 mRNA was elevated in APP expressing cells without EM treatment 
and no further induction was observed with EM. A 1.5- fold induction was observed in TfR protein after 




























    
   
Figure 4: EM increases expression of DMT1 and TfR1 in naïve and less in APP overexpressing SH-
SY5Y cells. (A) DMT1 and (B) TfR1 mRNA levels are expressed normalized to RPLPO using Bio-Rad 
CFX manager software. Results are expressed as the mean ± S.E.M.. (C) Western blot analysis of TfR. (D) 
Relative protein levels were analyzed with Image Studio and normalized to β-actin. **, p<0.05. ***,  
p<0.01. ****, p<0.0001. ns, not significant. (ANOVA, Tukey posthoc test) 
 
3.4 EM increases labile iron in SH-SY5Y cells  
The iron in the cell not bound to protein is referred to as the labile iron pool (LIP) and is analysed 
with the fluorescent dye calcien. Fluorescence quenching indicates inceases in the LIP. Significant 
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(Fig.5). Previous experiments have confirmed that no effect of EM on cell viability at 24 hours, indicating 
the decrease in calcein fluorescence is due to increase in LIP not cell dealth (data not shown here). 
Similarily, deferoxamine (DFE), a known iron chelator, was also found to increase LIP resulting in 
calcein fluorescence reduction (Fig.5).  
 
Figure 5: Effect of EM on labile iron pool in SH-SY5Y cells. Calcein AM reading was taken at 490 nm 
excitation and 520nm emission. ****, p<0.0001 (ANOVA, Tukey posthoc test) 
 
3.5 EM causes decrease in Iron Responsive Proteins (IRPs) in HEK 293 cells 
The bicistronic reporter construct was used to measure levels of IRP. The reporter genes are 
Yellow Fluorescence Protein (YFP) and Cyan Fluorescence Protein (CFP). CFP is constitutively 
expressed whereas YFP is regulated by an intracellular iron element located at the 5’ UTR. IRP binds to 
the 5’- of the mRNA resulting in a decrease in YFP mRNA translation (Fig. 6A). The assay was 
conducted in HEK293 cell line because of the better transfection efficiency. Treatment with EM at all 
concentrations for 24 hours caused significant decrease in YFP/CFP ratio (Fig. 6B). This means that IRP 






Figure 6. Effect of EM on iron responsive proteins (IRPs). (A) Schematic representation of the 
bicisronic reporter gene constructs. The RNA binding site is an IRE that will interact with the RNA 
binding protein iron response protein (IRP) resulting in less translation. (B) Assessment of IRP–IRE 
interaction in HEK 293 cells after transient transfection of the IRE-containing bicistronic reporter gene. 
Deferoxamine (DFE), a known iron chelator, was used as the positive control. ****, p<0.0001 (ANOVA, 
Tukey posthoc test). 
 
3.6 EM treatment increases DNA double strand breaks 
 Given that excess amount of intracellular iron can induce DNA damage, the effect of EM was 
determined on DNA integrity by measuring the percentage of cells with γ-H2AX foci. Foci were not 
observed in untreated cells (Fig.7A).  EM at 0.3mM and 1mM increased foci formation (Fig. 7C, D). 
Topoisomerase II Inhibitor etoposide was used as a positive control. As expected, an increase in the 
percentage of cells forming foci was observed following etoposide exposure (Fig.7B).  






Figure 7. EM increases the percentage of cells display γ-H2AX foci. (A) control (B) etoposide (C) EM 
0.3mM 36 hours (D) EM 1mM 36 hours quantification of number of foci per 100 DAPI positive cells. 
Results are expressed as the mean of 6 technical replicates ± S.E.M and variation was analyzed with one-
way ANOVA. ****, p<0.0001 (ANOVA, Tukey posthoc test). 
  
3.7 Retinoic Acid Induced Differentiation SH-SY5Y cells  
 The next series of experiments focused on the effects of EM on differentiated SH-SY5Y cells. 
RA and other neurotrophic factors have been shown to increase neurite outgrowth and other markers of 
differentiated neurons in SH-SY5Y cells.  
 
3.7.1 EM induces p21 gene expression.  
 In addition to induction of p21 levels in naïve SH-SY5Y cells after EM treatment, a 2-fold 
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Figure 8. Treatment with EM increases of p21 mRNA. EM increases the expression of p21 in RA-
induced SH-SY5Y cells. Relative gene expression was quantified by normalizing to RPLPO by Bio-Rad 
CFX manager software. ****, p<0.0001 (ANOVA, Tukey posthoc test). 
 
3.7.2 EM induces the expression of divalent metal transporter 1 (DMT1) and transferrin receptor 
(TfR1) in differentiated cells which are both attenuated in SH5Y-APP cells   
EM also affects iron homeostasis in differentiated cells. Greater than a 10-fold induction in 
DMT1 mRNA was observed in differentiated SH-SY5Y cells treated with 1mM EM for 72 hours 
compared to the control group (Fig.9A). EM also induced TfR1 mRNA expression in SH-SY5Y cells 
treated with 1mM EM for 72 hours by more than 5-fold and more than 10-fold at 0.3mM (Fig.9A). In 
contrast, DMT1 mRNA level was elevated in diffentiated APP expressing SH-SY5Y cells and no further 
change was observed with EM treatment (Fig.9B). TfR1 mRNA was also elevated in diffentiated APP 
expressing cells without EM treatment and only about 5-fold elevation of TfR mRNA level was found 





































Figure 9. Effect of EM on DMT1 and TfR1 in differentiated SH-SY5Y cells. Treatment with EM 
increases DMT1 and TfR1 mRNA expression in differentiated SH-SY5Y cells, which is attenuated in 
selected concentrations in SH-SY5Y cells overexpression of APP. (A,B) Samples were amplified in 
duplicates and relative gene expression was analyzed using Bio-Rad CFX manager software and 
normalized to RPLPO. Results are expressed as the mean ± S.E.M. Two-way ANOVA and multiple 
comparison were performed to generate P values between groups. ****, p<0.0001. ns, not significant.  
 
 
3. Discussion  
Our study is the first report that EM decreases cell viability in a neuron model. Viability was not 
detected after cells were exposed to EM at 1 mM for 48 hrs. The decrease in viability was likely attributed 
to DNA damage. An increase was observed in the percentage of cells displaying γ-H2AX foci. The foci 
represent sites of DNA deletions that are undergoing repair. γ-H2AX is the product of H2AX 
phosphorylation by ATM and ATM is the master regulator of the DNA damage response (Celeste et al., 
2003). The response has three branches including DNA repair, inhibiting the cell cycle, and apoptosis if 
the cell cannot sufficient repair the DNA. The latter two branches are induced through the activation of 
p53 (Celeste et al., 2003). Cell cycle inhibition is mediated by p53-mediated transcription of several genes 
including 14-3-3σ and p21. Considering we observed increased expression of 14-3-3σ and p21, it appears 
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We suggest that EM decreases viability by disrupting iron homeostasis. Dramatic increases were 
observed in DMT1 and TfR1, which are membrane proteins that mediate iron uptake. The mRNA of both 
genes has an IRE at the 3’UTR that binds to an IRP when iron levels are low. The increases in mRNA 
stability results in increases in iron transport. EM was found to increase binding of IRP to the IRE in the 
IRP reporter assay. We suggest that EM freely enters cells because it is a highly lipophilic compound and 
binds to the iron inside the cell. Because the intracellular iron is not available, IRP binds to IRE resulting 
in DMT1 and TfR1 mRNA stability. Increases in DMT1 and TfR would result in increases in iron uptake. 
Nie et al also found that deferoxamine induces IRP levels in the same reporter assay (Nie et al., 2006).  It 
is interesting that EM increases IRP binding to IRE and also increases the labile iron pool (LIP). Cells 
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